Investing Profile

Cory Freedland

InvestorVC
Partner at Samsara BioCapital
samsaracap.com/cory-freedland...San Francisco Bay Area
Photo of Cory Freedland, Partner at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Morgan Stanley Network
452 CONNECTIONS
Morgan Stanley Network
452 CONNECTIONS
Northwestern University - Kellogg School of Management Network
193 CONNECTIONS
cb
$1M - $100.0M
$25.0M
4
$310.1M
CompanyStageDateRound SizeTotal Raised
Alpha-9 Oncology
Series COct 2024$180M
Series BDec 2022$75M
$250M
Co-investors: Elena Viboch (General Catalyst), Patrick Heron (Frazier Healthcare Partners), Melissa McCracken (Nextech Invest)
Palvella Therapeutics
Series CMay 2020$45M
$45M
Velicept Therapeutics
Series BOct 2018$15M
$15M
Research Scientist II HotmailPresent
Summer Associate Merrill LynchPresent
Intern HadleyPresent
Associate, Healthcare Investment Banking Merrill LynchPresent
Associate, Healthcare Investment Banking Morgan StanleyPresent
Vice President, Healthcare Investment Banking Morgan StanleyPresent
Novo Ventures Novo HoldingsPresent
Associate Sofinnova InvestmentsPresent
Principal Sofinnova InvestmentsPresent
Consultant HotmailPresent
Partner Samsara BioCapitalPresent
Connecticut College B.A. Psychology, Religious Studies
Wake Forest University School of Medicine Ph.D. Pharmacology
Northwestern University - Kellogg School of Management MBA Analytical Finance, Accounting